Akèy › Skizofreni › New York
Etid klinik pou Skizofreni nan New York
23 etid pou Skizofreni ap chèche patisipan nan sit nan New York.
Vil nan New York
Tèks ofisyèl etid la (Anglè)
iTBS to Enhance Social Cognition in People With Psychosis
- Zucker Hillside Hospital, Glen Oaks
Ap rekrite
Laj 18 a 39 · Tout sèks · Mizajou Oct 1, 2026 · NCT06118268Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- Radial - Manhattan, New York
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07101094A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Neurobehavioral Research Inc, Cedarhurst
- Evolution Research Group, Staten Island
Ap rekriteFaz 1
Laj 18 a 55 · Tout sèks · Mizajou Sep 28, 2026 · NCT07615426Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- NYU Child Study Center, New York
- Richmond Behavioral Associates, Staten Island
Ap rekriteFaz 3
Laj 5 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT06229210NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Cedarhurst
- Neurocrine Clinical Site, New York
- Neurocrine Clinical Site, New York
- ak 2 plis
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07114874Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, Cedarhurst
- Neurocrine Clinical Site, New York
- Neurocrine Clinical Site, The Bronx
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07227818A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0061, Great Neck
- Local Institution - 0156, Staten Island
- Local Institution - 0151, The Bronx
Ap rekriteFaz 3
Laj 5 a 17 · Tout sèks · Mizajou Sep 22, 2026 · NCT07424404A Study of Brenipatide in Adult Participants With Schizophrenia
- Adams Clinical Harlem, New York
Ap rekriteFaz 2
Laj 18 a 55 · Tout sèks · Mizajou Sep 22, 2026 · NCT0741050752-week Open Label Safety-Tolerability Study
- Neuro-Behavioral Clinical Research, New York
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 9, 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Local Institution - 0061, Great Neck
Ap rekriteFaz 3
Laj 13 a 17 · Tout sèks · Mizajou Sep 4, 2026 · NCT07288567A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, New York
- Clinical Site, Staten Island
- Clinical Site, The Bronx
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 1, 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Local Institution - 0037, Buffalo
- Local Institution - 0004, Monsey
- Local Institution - 0038, Rochester
- ak 1 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT07379827Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, New York
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Aug 14, 2026 · NCT05303064Biomarkers to Enhance Early Schizophrenia Treatment
- Feinstein Institute for Medical Research, Glen Oaks
Ap rekriteFaz 4
Laj 18 a 35 · Tout sèks · Mizajou Jul 31, 2026 · NCT06969755MicroRNAs as Biomarkers in First Episode Schizophrenia
- Zucker Hillside Hospital, Glen Oaks
Ap rekriteVolontè an sante akeyi
Laj 15 a 40 · Tout sèks · Mizajou Jul 14, 2026 · NCT07703670A Virtual Reality Mindfulness Application for Aggression in Schizophrenia
- Manhattan Psychiatric Center, New York
- NewYork-Presbyterian/Weill Cornell Medical Center Westchester Division, White Plains
Ap rekrite
Laj 18 a 64 · Tout sèks · Mizajou Jun 10, 2026 · NCT07434479Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- NYU Langone Medical Center, New York
- New York State Psychiatric Institute, New York
- Manhattan Psychiatric Center, New York
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou May 4, 2026 · NCT05208190NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Staten Island
- Neurocrine Clinical Site, The Bronx
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Mar 6, 2026 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Staten Island
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jan 12, 2026 · NCT06961968Study of ALTO-101 in Patients With Schizophrenia
- Site 5108, New York
- Site 5077, New York
- Site 5126, White Plains
Ap rekriteFaz 2
Laj 21 a 55 · Tout sèks · Mizajou Dec 26, 2025 · NCT06502964Visual Perception in Schizophrenia
- University of Rochester, Rochester
Ap rekriteVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Nov 12, 2025 · NCT06911931Effectiveness of Motivation Skills Training (MST)
- The Bridge, Inc., New York
- New York State Office of Mental Health, New York
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Nov 5, 2025 · NCT05805397Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study
- Zucker Hillside Hospital, New York
Ap rekrite
Laj 18 a 60 · Tout sèks · Mizajou Sep 25, 2025 · NCT05389787Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.